Literature DB >> 2350346

Persistent effect of TGF-beta 1 on extracellular matrix gene expression in human dermal fibroblasts.

O Ishikawa1, A Yamakage, E C LeRoy, M Trojanowska.   

Abstract

TGF-beta, a potent inducer of the extracellular matrix, is also known to stimulate its own synthesis. In this report we have analyzed long term effects of TGF-beta 1 on its own expression and on the expression of extracellular matrix genes. We demonstrated that 24 hours of incubation of human dermal fibroblasts with TGF-beta 1 (1 ng/ml) under serum free conditions resulted in an elevated expression of TGF-beta 1, collagen alpha 2(I) and fibronectin mRNAs that persisted at least 96 hours after removal of TGF-beta 1. These data suggest the possibility of persistent in vivo activation of target cells following exposure to TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350346     DOI: 10.1016/0006-291x(90)91458-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.

Authors:  L S Beck; L DeGuzman; W P Lee; Y Xu; M W Siegel; E P Amento
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Trichostatin a inhibits corneal haze in vitro and in vivo.

Authors:  Ajay Sharma; Maneesh M Mehan; Sunilima Sinha; John W Cowden; Rajiv R Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-24       Impact factor: 4.799

3.  Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1.

Authors:  B A Arrick; A R Lopez; F Elfman; R Ebner; C H Damsky; R Derynck
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

4.  Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.

Authors:  A Yamakage; K Kikuchi; E A Smith; E C LeRoy; M Trojanowska
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.